PROTECTIVE EFFECTS OF HUMAN PARATHYROID-HORMONE (1-34) ON BONE MASS AND STRENGTH IN OVARIECTOMIZED RATS

被引：0
|
作者：
OKIMOTO, N
NAKAMURA, T
HORI, M
OKAZAKI, Y
AOTA, S
SUZUKI, K
机构：
[1] UNIV OCCUPAT & ENVIRONM HLTH,KITAKYUSHU,FUKUOKA 807,JAPAN
[2] ASAHI CHEM CORP,PHARMACOL BASIC RES LABS,SHIZUOKA,JAPAN
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1995年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [41] EFFECTS OF PARATHYROID-HORMONE AND THE SYNTHETIC 1-34 AMINO-TERMINAL FRAGMENT IN RATS AND DOGS
    STEVENSON, RW
    PARSONS, JA
    [J]. JOURNAL OF ENDOCRINOLOGY, 1983, 97 (01) : 21 - 30
  • [42] Intermittent weekly administration of human parathyroid hormone (1-34) improves bone-hydroxyapatite block bonding in ovariectomized rats
    Kamo, Keiji
    Miyakoshi, Naohisa
    Kasukawa, Yuji
    Nozaka, Koji
    Sasaki, Hiroshi
    Shimada, Yoichi
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (06) : 634 - 640
  • [43] Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats
    McManus, Julie F.
    Davey, Rachel A.
    MacLean, Helen E.
    Doust, Elizabeth A.
    Chiu, W. S. Maria
    Sims, Natalie A.
    Bouxsein, Mary L.
    Glatt, Vaida
    Zajac, Jeffrey D.
    Danks, Janine A.
    [J]. BONE, 2008, 42 (06) : 1164 - 1174
  • [44] Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin
    Dani B.A.
    DeLuca P.P.
    [J]. AAPS PharmSci, 3 (4): : XIII - XIV
  • [45] Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin
    Dani, BA
    DeLuca, PP
    [J]. AAPS PHARMSCI, 2001, 3 (04):
  • [46] Combined antisclerostin antibody and parathyroid hormone (1-34) synergistically enhance the healing of bone defects in ovariectomized rats
    Lin, Jinti
    Wu, Jun
    Sun, Shuaibo
    Chen, Kai
    Wu, Hongqiang
    Lin, Renjin
    Zhou, Chengwei
    Kong, Jianzhong
    Zhou, Kailiang
    Shui, Xiaolong
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2020, 53 (02): : 163 - 170
  • [47] COMPARISON OF POSTRECEPTOR EFFECTS OF 1-34 HUMAN HYPERCALCEMIA FACTOR AND 1-34 HUMAN PARATHYROID-HORMONE IN RAT OSTEO-SARCOMA CELLS
    RODAN, SB
    NODA, M
    WESOLOWSKI, G
    ROSENBLATT, M
    RODAN, GA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (03): : 924 - 927
  • [48] Parathyroid hormone (1-34) increased total body bone mass in aged female rats
    Simmons, HA
    Pirie, CM
    Thompson, DD
    Ke, HZ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (01): : 341 - 344
  • [49] EFFECTS OF SALMON-CALCITONIN IN OSTEOPOROTIC PATIENTS TREATED WITH HUMAN PARATHYROID-HORMONE 1-34
    SLOVIK, DM
    NEER, RM
    MEUNIER, P
    POTTS, JT
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1979, 28 (02) : 160 - 160
  • [50] Anabolic effects of recombinant human parathyroid hormone (1-84) and synthetic human parathyroid hormone (1-34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction
    Kawane, T
    Takahashi, S
    Saitoh, H
    Okamoto, H
    Kubodera, N
    Horiuchi, N
    [J]. HORMONE AND METABOLIC RESEARCH, 2002, 34 (06) : 293 - 302
12345